Cited by 16Thyroid Cancer Diagnosis and TreatmentEconomic and Financial Impacts of CancerThyroid and Parathyroid Surgery

The Economic Cost of Thyroid Cancer in France and the Corresponding Share Associated With Treatment of Overdiagnosed Cases

Open access
Li, Mengmeng, Meheus, Filip, Polazzi, Stephanie, Delafosse, Patricia, Borson-Chazot, Françoise, Seigneurin, Arnaud, Simon, Raphael, Combes, Jean-Damien +4 more·2023·Value in Health

Abstract

Objectives Thyroid cancer incidence in France has increased rapidly in recent decades. Most of this increase has been attributed to overdiagnosis, the major consequence of which is overtreatment. We aimed to estimate the cost of thyroid cancer management in France and the corresponding cost proportion attributable to the treatment of overdiagnosed cases. Methods Multiple data sources were integrated: the mean cost per patient with thyroid cancer was estimated by using the Echantillon Généraliste des Bénéficiaires data set; thyroid cancer cases attributable to overdiagnosis were estimated for 21 departments using data from the French network of cancer registries and extrapolated to the whole country; medical records from 6 departments were used to refine the diagnosis and care pathway. Results Between 2011 and 2015, 33 911 women and 10 846 men in France were estimated to be diagnosed of thyroid cancer, with mean cost per capita of €6248. Among those treated, 8114 to 14 925 women and 1465 to 3626 men were due to overdiagnosis. The total cost of thyroid cancer patient management was €203.5 million (€154.3 million for women and €49.3 million for men), of which between €59.9 million (or 29.4% of the total cost, lower bound) and €115.9 million (or 56.9% of the total cost, upper bound) attributable to treatment of overdiagnosed cases. Conclusions The management of thyroid cancer represents not only a relevant clinical and public health problem in France but also a potentially important economic burden. Overdiagnosis and corresponding associated treatments play an important role on the total costs of thyroid cancer management.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jval.2023.02.016

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Tuppin P, Pestel L, Samson S, et al. [The human and economic burden of cancer in France in 2014, based on the SNIIRAM national database]. Bull Cancer. 2017;104(6):524-537.
  2. Mathonnet M, Cuerq A, Fagot-Campagna A, et al. Analysis of the care pathway for patients who have undergone thyroidectomy in France, for cancer, goiter or nodule. Ann Endocrinol. 2013;74(4):255.

Cited by

Sorted by citations

Authors
Li, M., Meheus, F., Polazzi, S., Delafosse, P., Borson-Chazot, F., Seigneurin, A., Simon, R., Combes, J.-D., Dal Maso, L., Colonna, M., Duclos, A., & Vaccarella, S.
Affiliations
  • Sun Yat-sen University (CN)
  • World Health Organization (CH)
  • Centre international de recherche sur le cancer (FR)
  • Lyon 1 Université (FR)
Corresponding author
Vaccarella, Salvatore
Venue
Value in Health
Publisher
Elsevier BV
Published
2023-08
Volume
26
Issue
8
Pages
1175-1182
ISSN
1098-3015 (ISSN-L)
OpenAlex
W4324044629
Cited by
15
References
30
Citations by year
2026: 3 · 2025: 6 · 2024: 4 · 2023: 2
FWCI
3.07
Type
journal article
Language
en
Open access
Locations
  • Value in Health (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • Associazione Italiana per la Ricerca sul Cancro (21879)
  • Institut National Du Cancer (2017-138)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
Keywords
thyroid cancer, overdiagnosis, overtreatment, economic burden, health care costs, cancer incidence
MeSH terms
Female, France, Humans, Male, Thyroid Neoplasms, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review